Conference Papers in Science

Conference Paper

Essentials of Oncothermia

Table 1

Collection of the studies (phase II) made by oncothermia in combination with various conventional oncotherapies. (Data are weighted averages of the study results.)


Study	Number of studies	Number of patients ()	1st year survival (%)	Median overall survival (m)	Responding patients/ratio (%)	Median overall survival of responding patients (m)	Median overall survival of nonresponding patients (m)

Brain studies	10	521	73.99	22.19	44.09	51.31	15.88
Pancreas studies	6	184	47.04	11.02	53.05	28.09	7.58
Lung studies	5	636	64.76	15.79	25.73
Bone	3	79		40.10	90.90
Liver metastasis	7	267	86.00	18.06	80.00
Colorectal	7	447			63.18	109.80	23.20
Gynecology (pelvic)	5	100	93.22	33.25	44.82	89.36	21.70
Breast	1	103	97.10	52.10	45.00	274.80	10.90
Esophagus	2	19	41.70	55.64	35.00	29.40	8.50
Stomach study	1	68	58.90	14.40
Kidney cancer	1	39	84.60	35.90	48.00	78.40	33.70
Urinary bladder cancer	1	18	85.00	36.50	73.00	42.00	22.60
Head and neck	1	64	92.20	26.10
Soft tissue sarcoma	1	16	100.00	35.90	31.00	115.30	31.30
Prostate	3	135	88.90	38.80	72.00	53.40	7.60

SUM	54	2796			51.63